[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: NEJM editorial on open access
- To: liblicense-l@lists.yale.edu
- Subject: Re: NEJM editorial on open access
- From: Joseph Esposito <espositoj@gmail.com>
- Date: Tue, 19 Oct 2004 18:13:39 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
The "this" is the distinction between having no copyright at all and having the limited copyright that is implicit in the NIH proposal, at least as I understand it. The NIH apparently is insisting that for articles based on NIH-funded research, the authors are free to assign only NONEXCLUSIVE rights to a publisher after six months have elapsed (but six months from when? That is not clear to me). There is a distinction in this formulation between this limited copyright and no copyright. But there is no practical difference in that libraries and some individuals will begin cancelling subscriptions when they see more and more articles becoming available at no charge after six months, accessible to anyone who can Google for them. Hence a distinction without a difference. This is not an argument, incidentally, against either Open Access (of whatever flavor) or the NIH proposal. It simply is a plea that we accept the consequences of our actions, which in this case will be the flight of capital from scholarly publishing. Some would say that this is a good thing. Joe Esposito On Mon, 18 Oct 2004 18:38:12 EDT, Michael Carroll wrote: > Joe Esposito wrote: > <<This is what is known as a distinction without a difference.>> > > What is the "this" to which you refer. The distinction between having a > copyright and not having one?
- Prev by Date: International Society on Thrombosis and Haemostasis - announcement
- Next by Date: RE: More on "information wants to be free"
- Previous by thread: Re: NEJM editorial on open access
- Next by thread: Re: NEJM editorial on open access
- Index(es):